Israel Englander Keros Therapeutics, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 572,990 shares of KROS stock, worth $32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
572,990
Previous 10,000
5629.9%
Holding current value
$32 Million
Previous $457,000
7180.74%
% of portfolio
0.02%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding KROS
# of Institutions
174Shares Held
30.3MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$141 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$106 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$104 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$85.2 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$84.7 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.44B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...